Company reports preliminary Q2 2026 AUCATZYL net product revenue of approximately $45 million and gross margin of approximately 35% year-to-date
FY 2026 sales guidance increased to $140 – $150 million, from $120 – $135 million
Capital base strengthened through five-year, interest-only credit facility with $75 million funded at close
Autolus to report Q2 2026 financial results on August 11, 2026

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.